SYU-30431-44809
3 vaccinations
5 coded responses
23 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2021-08-04
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-03
Dose 1 — Pfizer-BioNTech
-
2021-08-04
Registered in v-safe
- 2021-08-04
- 2021-08-05
- 2021-08-06
-
2021-08-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-08-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-10
- 2021-08-17
-
2021-08-24
Dose 2 — Pfizer-BioNTech
- 2021-08-24
-
2021-08-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-08-26
-
2021-08-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-08-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body achesAdult check-in
- 2021-08-30
- 2021-08-31
-
2021-09-07
Survey response — day 14, dose 2MedDRA: Influenza like illness — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Flu like symptomsMedDRA releases: 2024-11 · check-in free text available
- 2021-09-14
- 2021-09-21
- 2021-09-28
- 2021-10-05
-
2021-11-23
Survey response — 3 months, dose 2MedDRA: Influenza like illness — Feeling: Poor · Be unable to work or attend schoolFree text: Flu like symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Dose 3 — Pfizer-BioNTech
-
2022-02-22
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Covid positiveMedDRA releases: 2024-11 · check-in free text available
-
2022-08-21
Survey response — 6 months, dose 3MedDRA: Ovarian cyst, Pelvic pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: pelvic pain due to ovarian cystMedDRA releases: 2024-11 · check-in free text available
-
2023-02-22
Survey response — 12 months, dose 3MedDRA: Upper respiratory tract infection — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-03 | Pfizer-BioNTech | No |
| 2 | 2021-08-24 | Pfizer-BioNTech | No |
| 3 | 2022-02-20 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 2
Symptoms: Flu like symptoms
Release 10 — 3 months, dose 2
Symptoms: Flu like symptoms
Release 11 — 6 months, dose 2
Symptoms: Covid positive
Release 12 — 6 months, dose 3
Symptoms: pelvic pain due to ovarian cyst
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Ovarian cyst | · | · | ✓ |
| SD | Pelvic pain | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release